| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | BUY | BUY | BUY | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 77.18▼ | 76.76▼ | 76.68▼ | 76.52▲ | 75.30▲ |
| MA10 | 77.09▼ | 76.65▼ | 76.47▲ | 75.35▲ | 78.65▼ |
| MA20 | 76.90▼ | 76.34▲ | 76.38▲ | 74.86▲ | 83.85▼ |
| MA50 | 76.67▼ | 76.13▲ | 76.01▲ | 79.27▼ | 86.44▼ |
| MA100 | 76.11▲ | 75.77▲ | 74.82▲ | 85.08▼ | 76.01▲ |
| MA200 | 76.14▲ | 74.84▲ | 76.39▲ | 89.10▼ | 75.71▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.010▼ | 0.047▲ | 0.037▲ | 0.619▲ | -1.278▼ |
| RSI | 43.615▼ | 52.394▲ | 52.871▲ | 50.182▲ | 37.956▼ |
| STOCH | 70.214 | 72.033 | 81.020▲ | 74.246 | 26.451 |
| WILL %R | -100.000▼ | -44.186 | -33.655 | -23.862▲ | -64.946 |
| CCI | -85.603 | 89.844 | 99.682 | 90.689 | -68.033 |
|
Thursday, May 01, 2025 12:00 AM
NEW YORK, May 01, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today ...
|
|
Wednesday, April 30, 2025 04:30 AM
Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments for Alzheimer's disease, Parkinson's ...
|
|
Wednesday, April 30, 2025 04:28 AM
Supernus' reliance on Qelbree is increasing, but generic competition for other drugs poses challenges. Read why I downgrade SUPN stock from buy to hold.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 01/05/25 | 76.70 | 77.665 | 75.26 | 76.73 | 190,962 |
| 30/04/25 | 76.47 | 76.47 | 73.86 | 76.32 | 173,992 |
| 29/04/25 | 76.44 | 77.40 | 75.35 | 77.155 | 67,915 |
| 28/04/25 | 75.94 | 76.92 | 75.03 | 76.19 | 109,900 |
| 25/04/25 | 76.50 | 76.525 | 75.39 | 76.20 | 99,241 |
| 24/04/25 | 74.46 | 77.03 | 74.46 | 76.85 | 139,200 |
| 23/04/25 | 76.53 | 78.695 | 74.23 | 74.25 | 162,187 |
| 22/04/25 | 72.71 | 74.38 | 71.46 | 74.32 | 307,500 |
| 21/04/25 | 72.93 | 73.45 | 70.46 | 71.22 | 300,500 |
| 17/04/25 | 71.67 | 76.50 | 71.67 | 74.26 | 335,800 |
|
|
||||
|
|
||||
|
|